SAB-142 From SAb Biotherapeutics Starts a Phase II Trial (SAFEGUARD)

Back in April, I blogged about a Phase-II study called "Anti-Thymocyte Globulin and Verapamil Start A Phase-2 Clinical Trial" (NCT06455319). I should have included this trial at the same time, since they are closely related, but I didn't so I'm publishing this blog, now. Both studies are testing ATG in honeymooners. The previous study was testing either just ATG or ATG and Verapamil. This study is…